Bioterrorism Watch Archives – January 1, 2005
January 1, 2005
View Issues
-
Bioengineering smallpox: Rethinking the unthinkable
While the United States has taken steps to prepare for smallpox bioterrorism event, the nation remains starkly vulnerable to a genetically engineered strain of the deadly virus. -
Instant hospital aims to meet bioterror surge
From a large-scale bioterror attack to extreme natural disasters, were constantly reminded of looming safety threats and the U.S. infrastructures need to respond. And perhaps no industry has taken the threat more seriously than health care. -
Bioterror mail threats continue to be reported
A large number of potentially suspicious letters and packages continue to be reported to federal, state, and local law enforcement and emergency response agencies nationwide, the Nov. 2, 2004, report states. In some instances, these letters or packages may include powders, liquids, or other materials. -
New bioterror vaccines are getting in the pipeline
The federal government has awarded $232 million to fund research and development of new vaccines against three potential agents of bioterrorism: smallpox, plague, and tularemia. -
Anthrax vaccination policy dropped after court ruling
The Department of Defense (DoD) has halted mandatory anthrax vaccinations of military personnel after a ruling by the U.S. District Court for the District of Columbia. -
Abstract & Commentary: B. cereus mimics anthrax infection
A previously healthy patient presented with a two-day history of nausea, vomiting, hemoptysis, shortness of breath, and fever. His chest X-ray was abnormal, and his WBC on admission was 12,000/mm3, subsequently rising to a peak of 22,400/mm3.